Preoperative therapy for pancreatic adenocarcinoma—precision beyond anatomy
Despite recent advances in the systemic treatment of gastrointestinal tumors, pancreatic
adenocarcinoma (PDAC) remains a challenging disease, with 5‐year survival just over 10 …
adenocarcinoma (PDAC) remains a challenging disease, with 5‐year survival just over 10 …
The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature …
L Evangelista, P Zucchetta, L Moletta, S Serafini… - Annals of Nuclear …, 2021 - Springer
The aim of the present systematic review is to examine the role of fluorodeoxyglucose (FDG)
positron emission tomography (PET) associated with computed tomography (CT) or …
positron emission tomography (PET) associated with computed tomography (CT) or …
FDG-PET predicts neoadjuvant therapy response and survival in borderline resectable/locally advanced pancreatic adenocarcinoma
AM Abdelrahman, AH Goenka, R Alva-Ruiz… - Journal of the National …, 2022 - jnccn.org
Background: Neoadjuvant therapy (NAT) is used in borderline resectable/locally advanced
(BR/LA) pancreatic ductal adenocarcinoma (PDAC). Anatomic imaging (CT/MRI) poorly …
(BR/LA) pancreatic ductal adenocarcinoma (PDAC). Anatomic imaging (CT/MRI) poorly …
Radiomics-based machine-learning models can detect pancreatic cancer on prediagnostic computed tomography scans at a substantial lead time before clinical …
Background & Aims Our purpose was to detect pancreatic ductal adenocarcinoma (PDAC)
at the prediagnostic stage (3–36 months before clinical diagnosis) using radiomics-based …
at the prediagnostic stage (3–36 months before clinical diagnosis) using radiomics-based …
Neoadjuvant chemotherapy switch in borderline resectable/locally advanced pancreatic cancer
R Alva-Ruiz, L Yohanathan, JA Yonkus… - Annals of surgical …, 2022 - Springer
Background Neoadjuvant chemotherapy (NAC) is an integral part of preoperative treatment
for patients with borderline resectable/locally advanced (BR/LA) pancreatic ductal …
for patients with borderline resectable/locally advanced (BR/LA) pancreatic ductal …
New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (JSHBPS)
A Oba, M Del Chiaro, S Satoi, SW Kim… - Journal of Hepato …, 2022 - Wiley Online Library
The symposium “New criteria of resectability for pancreatic cancer” was held during the
33nd meeting of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (JSHBPS) in …
33nd meeting of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (JSHBPS) in …
Surgical considerations for neoadjuvant therapy for pancreatic adenocarcinoma
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a morbid malignancy with
discouraging survival rates. Enthusiasm for pre-operative therapy (chemotherapy, radiation …
discouraging survival rates. Enthusiasm for pre-operative therapy (chemotherapy, radiation …
Applications of PET/MRI in abdominopelvic oncology
SJ Galgano, CE Calderone, C Xie, EN Smith… - Radiographics, 2021 - pubs.rsna.org
With PET/MRI, the strengths of PET and MRI are combined to allow simultaneous image
acquisition and near-perfect image coregistration. MRI is increasingly being used for staging …
acquisition and near-perfect image coregistration. MRI is increasingly being used for staging …
Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-of-care CTs
Objectives To develop a bounding-box-based 3D convolutional neural network (CNN) for
user-guided volumetric pancreas ductal adenocarcinoma (PDA) segmentation. Methods …
user-guided volumetric pancreas ductal adenocarcinoma (PDA) segmentation. Methods …
Perineural invasion and spread in common abdominopelvic diseases: imaging diagnosis and clinical significance
Malignancies and other diseases may spread by multiple pathways, including direct
extension, hematogenous spread, or via lymphatic vessels. A less-well-understood route is …
extension, hematogenous spread, or via lymphatic vessels. A less-well-understood route is …